Precision’s early HBV gene editing data are mixed as biotech lays off staff to save cashnews2025-08-06T15:25:20+00:00August 6th, 2025|Endpoints News|
Novo Nordisk’s pipeline cull prompts hopes of strategic shiftnews2025-08-06T10:39:45+00:00August 6th, 2025|Endpoints News|
AstraZeneca culls plans for Evusheld successor in the US following Covid evolutionnews2025-08-06T01:29:00+00:00August 6th, 2025|Endpoints News|
Kennedy says BARDA will cancel 22 mRNA vaccine contractsnews2025-08-05T23:01:56+00:00August 5th, 2025|Endpoints News|
Beam delays key AATD readout, reveals plans to dose patients twicenews2025-08-05T17:58:24+00:00August 5th, 2025|Endpoints News|
Pfizer says some tariffs and MFN impact factored in guidancenews2025-08-05T11:33:21+00:00August 5th, 2025|Endpoints News|
HMNC Brain Health plans Phase 3 for ex-Sanofi depression drug despite mid-stage missnews2025-08-05T10:00:55+00:00August 5th, 2025|Endpoints News|
Vertex’s top scientist Altshuler to retire, next-generation pain drug failsnews2025-08-05T00:57:40+00:00August 5th, 2025|Endpoints News|
J&J divests from some of its incubator sitesnews2025-08-04T19:47:20+00:00August 4th, 2025|Endpoints News|
Praxis’ epilepsy drug cut seizure frequency in mid-stage trialnews2025-08-04T17:50:31+00:00August 4th, 2025|Endpoints News|
